South Florida Ent Associates Cc10 is categorized under Primary Care Centers in Miami, FL and active since 2010.
South Florida Ent Associates Cc10 was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Primary Care Centers business, which does work in the B2C market, and is classified as a Primary Care Centers, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Alejandro Espaillat at the company’s single location by writing to 1321 Nw 14th St, Miami, Florida FL 33125 or by phoning (305) 325-0090. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | South Florida Ent Associates Cc10 |
| Contact Person: | Alejandro Espaillat |
| Address: | 1321 Nw 14th St, Miami, Florida 33125 |
| Phone Number: | (305) 325-0090 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Primary Care Centers |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
South Florida Ent Associates Cc10 was started in 2010 to provide professional Primary Care Centers under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Alejandro Espaillat for inquiries that concern South Florida Ent Associates Cc10 by calling the company number (305) 325-0090, as your correspondence is most welcome. Additionally, the physical location of the single location of South Florida Ent Associates Cc10 can be found at the coordinates 25.787687,-80.216706 as well as the street address 1321 Nw 14th St in Miami, Florida 33125.
For its online presence, you may visit South Florida Ent Associates Cc10’s website at and engage with its social media outlets through on Twitter and on Facebook.